Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
Title:
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
Author:
Zhu, Feng-Cai Wurie, Alie H Hou, Li-Hua Liang, Qi Li, Yu-Hua Russell, James B W Wu, Shi-Po Li, Jing-Xin Hu, Yue-Mei Guo, Qiang Xu, Wen-Bo Wurie, Abdul R Wang, Wen-Juan Zhang, Zhe Yin, Wen-Jiao Ghazzawi, Manal Zhang, Xu Duan, Lei Wang, Jun-Zhi Chen, Wei